Advance Agrolife Limited: Monitoring Agency Report for IPO Proceeds Utilization (Quarter Ended March 31, 2026)
Advance Agrolife Limited's Monitoring Agency Report for Q4FY26 shows IPO proceeds utilization is as per the offer document. Out of ₹192.84 crore raised, ₹98.82 crore has been utilized as of March 31, 2026. Unutilized funds of ₹67.79 crore are invested in fixed deposits and monitoring accounts.
This is a standard post-IPO compliance report. While it provides transparency on fund utilization, it does not introduce new material information that would significantly impact the company's stock price or investor decisions beyond confirming adherence to regulations.
The report is a routine compliance filing detailing the utilization of IPO proceeds. It confirms that the utilization is in line with the offer document, indicating no negative developments but also no significantly positive news beyond the adherence to plan.
Advance Agrolife Limited has submitted its Monitoring Agency Report for the utilization of proceeds raised through its Initial Public Offering (IPO) for the quarter ended March 31, 2026. The report, issued by CARE Ratings Limited, confirms that the utilization of funds is in line with the disclosures made in the Offer Document.
The company raised ₹192.84 crore through its IPO. The monitoring agency report indicates that as of March 31, 2026, a total of ₹98.82 crore had been utilized, with ₹26.23 crore utilized during the fourth quarter of fiscal year 2026. The unutilized amount stands at ₹67.79 crore.
Of the total IPO proceeds, ₹135.00 crore was earmarked for funding working capital requirements, ₹34.08 crore for general corporate purposes, and ₹23.76 crore for issue-related expenses. The report details that ₹67.50 crore of unutilized working capital funds have been invested in a fixed deposit with Punjab National Bank, maturing on April 15, 2026, yielding a return of 6.03%. An additional ₹0.29 crore is held in a monitoring account with HDFC Bank.
The report also specifies that ₹25.92 crore from the general corporate purposes fund was utilized for capital expenditure, as per board resolutions. A total of ₹23.16 crore of the issue-related expenses had been utilized by the end of the quarter, with ₹0.31 crore spent during Q4FY26.
CARE Ratings Limited has confirmed that there are no deviations from the objects stated in the offer document and no material deviations in expenditures. The company has also confirmed that there is no change in the means of finance for the disclosed objects.
What to do with a filing like this
Advance Agrolife Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Advance Agrolife Limited. Read the original for the full detail.